[Federal Register Volume 67, Number 226 (Friday, November 22, 2002)]
[Notices]
[Page 70446]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-29688]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines (ACCV); Notice of 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Public Law 92-463), notice is hereby given of the 
following meeting. The meeting will be open to the public.

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: December 4, 2002; 9 a.m.-5 p.m.
    Place: Audio Conference Call and Parklawn Building, Conference 
Rooms G & H, 5600 Fishers Lane, Rockville, Maryland 20857.
    The public can join the meeting in person at the address listed 
above or by audio conference call by dialing 1-877-960-9066 on 
December 4 and providing the following information:
    Leader's Name: Thomas E. Balbier, Jr.
    Password: ACCV.
    Agenda: The agenda items for December 4 will include, but not 
limited to: an update on thimerosal class action lawsuits; a 
discussion of the revised National Vaccine Injury Compensation 
Program's Strategic Plan, a presentation on the Institute of 
Medicine's report, ``SV40 Contamination of Polio Vaccine and 
Cancer,'' and updates from the Division of Vaccine Injury 
Compensation, the Department of Justice, and the National Vaccine 
Program Office. Agenda items are subject to change as priorities 
dictate.
    Public Comments: Persons interested in providing an oral 
presentation should submit a written request, along with a copy of 
their presentation to: Ms. Cheryl Lee, Principal Staff Liaison, 
Division of Vaccine Injury Compensation, Office of Special Programs, 
Health Resources and Services Administration, Room 16C-17, 5600 
Fishers Lane, Rockville, MD 20857 or by e-mail at [email protected]. 
Requests should contain the name, address, telephone number, and any 
business or professional affiliation of the person desiring to make 
an oral presentation. Groups having similar interests are requested 
to combine their comments and present them through a single 
representative. The allocation of time may be adjusted to 
accommodate the level of expressed interest. The Division of Vaccine 
Injury Compensation will notify each presenter by mail or telephone 
of their assigned presentation time. Persons who do not file an 
advance request for a presentation, but desire to make an oral 
statement, may announce it at the time of the comment period on the 
audio conference call. These persons will be allocated time as time 
permits.
    For Further Information Contact: Anyone requiring information 
regarding the ACCV should contact Ms. Cheryl Lee, Principal Staff 
Liaison, Division of Vaccine Injury Compensation, Office of Special 
Programs, Health Resources and Services Administration, Room 16C-17, 
5600 Fishers Lane, Rockville, Maryland 20857, telephone (301) 443-
2124 or e-mail: [email protected].


    Dated: November 15, 2002.
Jon L. Nelson,
Associate Administrator for Management and Program Support.
[FR Doc. 02-29688 Filed 11-21-02; 8:45 am]
BILLING CODE 4165-15-P